The FGFRL1-FASN axis regulates neuroendocrine lineage transdifferentiation by modulating fatty acid synthesis in AR

Yupeng Chen1, Jiarun Lai2, Jian Chen1

  • 1Department of Urology, School of Medicine, The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital), Guangzhou, 510180, China.

Cancer Letters
|July 28, 2026
PubMed

Insights

Neuroendocrine prostate cancer (NEPC) is a low fatty acid synthesis state linked to poor survival. The FGFRL1-FASN metabolic axis regulates NEPC transdifferentiation and metastasis in AR pathway-independent prostate cancer.

Area of Science:

  • Oncology
  • Metabolic pathways
  • Cancer biology

Background:

  • AR pathway-independent prostate cancer (ARIPC), especially neuroendocrine prostate cancer (NEPC), is a lethal form of metastatic castration-resistant prostate cancer (mCRPC).
  • The role of fatty acid synthesis (FAS) in ARIPC and its influence on neuroendocrine lineage transdifferentiation are not well understood.

Purpose of the Study:

  • To investigate the organization of FAS in ARIPC.
  • To determine if distinct lipogenic states influence neuroendocrine lineage transdifferentiation.
  • To identify key molecular players in this process.

Main Methods:

  • Integration of single-cell and bulk transcriptomic analyses of mCRPC cohorts.
  • Functional studies involving depletion and restoration of fatty acid synthase (FASN) and FGFRL1.
  • Targeted gas chromatography-mass spectrometry (GC-MS) and fluorescent uptake assays.
  • Directional perturbation, rescue, AKT phosphorylation, and co-immunoprecipitation analyses.

Main Results:

  • NEPC is characterized as a fatty-acid-synthesis-low state associated with poor survival.
  • FASN is a key indicator and functional driver of lipogenic activity; its depletion suppresses lipogenesis but enhances NEPC programs and metastasis.
  • FGFRL1 is identified as a key regulator of FAS in ARIPC, influencing FASN expression and fatty acid content.
  • The FGFRL1-FASN axis was functionally validated, and ONECUT2 was identified as a downstream regulator.

Conclusions:

  • An FGFRL1-FASN metabolic axis plays a crucial role in regulating neuroendocrine lineage transdifferentiation.
  • This axis is implicated in the metastatic progression of AR pathway-independent prostate cancer.
  • Targeting this metabolic pathway may offer therapeutic strategies for aggressive prostate cancer.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...